Introduction: A comprehensive geriatric assessment systematically collects information on geriatric conditions and is propagated in oncology as a useful tool when assessing older cancer patients. Objective: 1) to study the prevalence of geriatric conditions in cancer patients aged ≥65 years, acutely admitted to a general medicine ward, 2) to determine functional decline and mortality within twelve months after admission, and 3) to assess which geriatric conditions and cancer-related variables are associated with twelve-month-mortality. Method: An observational cohort study of 292 cancer patients ≥65 years, acutely admitted to the general medicine and oncology ward of two university and one secondary teaching hospital. Baseline assessment included patient characteristics, reason for admission, comorbidity and geriatric conditions. Follow-up at three and twelve months was aimed at functional decline (loss of 1 in ADL-activities) and mortality. Results: Median age was 74.9 years, and 95% lived independently; 126 patients (43%) had metastatic disease. A high prevalence of geriatric conditions was found for IADL impairment (78%), depressive symptoms (65%), pain (65%), impaired mobility (48%), malnutrition (46%) and ADL impairment (38%). Functional decline was observed in 8% and 33% of patients at three and twelve months, respectively. Mortality rates were 38% at three months and 64% at twelve months. Mortality was associated with cancer-related factors only. Conclusion: In these acutely hospitalized older cancer patients, mortality was only associated with cancer-related factors. The prevalence of geriatric conditions in this population was high. Future research is needed to elucidate if addressing these conditions can improve quality of life.
Introduction
Although malignant tumours occur at all ages, cancer disproportionately strikes individuals aged 65 years and older. 1 Data from the National Cancer Institute Surveillance, Epidemiology, and End Results Program reveal that over half of all newly diagnosed cancer patients and more than two-thirds of cancer deaths are in this age group. 2 In western societies, the number of older cancer patients will increase substantially in the coming decades as a result of increasing life expectancy and ageing of the population. Oncologists are faced with the challenge of how to determine what treatment is suitable for their older cancer patients, with their heterogeneity in comorbidity, physical reserve, disability and geriatric conditions. Age and performance status are too limited to do justice to this diversity, 3, 4 and as guidelines for cancer treatment are often based on trials from which older patients and patients with comorbidity have been excluded, 5 these guidelines cannot automatically be extrapolated to all ages. Therefore, the use of a comprehensive geriatric assessment (CGA) -a systematic procedure to appraise the objective health status of older people, focusing on somatic, functional and psychosocial domains -is frequently propagated in oncology as the tool to fill in these gaps. 4, [6] [7] [8] [9] [10] [11] It is thought that identifying those factors associated with poor outcome will aid in prognostication and decision making regarding treatment for the individual patient. 10, 12 Furthermore, modifying the conditions identified with a CGA could improve outcome and health-related quality of life, 7, 13, 14 particularly since geriatric conditions are often missed if they are not specifically looked for. [7] [8] [9] 15 Although many editorials and review articles endorse the use of CGA in geriatric oncology, publication of evidence supporting this assumption of an added value of systematic CGA above usual care is far less frequent. 4, 5, [7] [8] [9] [10] 12, 14, [16] [17] [18] [19] In addition, due to heterogeneity in study population (inpatients vs. outpatients) and study setting (oncology vs. geriatric medicine vs. general medicine) as well as the large variation in the extensiveness of the CGA administered, data remain fragmentary and inconclusive on the association between CGA and outcome.
One setting in which CGA may be of added value is for older cancer patients requiring acute hospitalization, for example when an acute illness reveals the presence of malignancy or due to cancer-or treatment-related complications in the course of the disease. Independent of the reason for admission, choices need to be made about future course of treatment during hospitalization. Furthermore, acutely ill patients could be at increased risk for geriatric conditions and functional decline. Therefore, we studied the value of a CGA for older cancer patients acutely admitted to the general medicine and oncology departments of three hospitals. The aim of the present study was threefold: 1) to study the prevalence of geriatric conditions in cancer patients aged 65 years and older acutely admitted to a general medicine ward, 2) to determine functional decline and mortality within twelve months after admission and 3) to assess which geriatric conditions and cancer-related variables are associated with twelve-month ortality. m
Method

Patients
This is an observational substudy of cancer patients who were included in the DEFENCE-I and -II studies (Development of strategies Enabling Frail Elderly New Complications to Evade). 20, 21 The DEFENCE-I study (n=647) was conducted at the Academic Medical Centre In these prospective cohort studies, all patients aged 65 years and older, acutely admitted to the general medicine or oncology ward were included. Patients were excluded if 1) they or their relatives did not give informed consent, 2) they were too ill to participate according to their attending physician, 3) they came from another ward inside or outside the hospital, 4) they were transferred to the intensive care unit, coronary care unit or another ward inside or outside the hospital within 48 hours after admission, or 5) they were unable to speak or understand Dutch. Inclusion had to take place within 48 hours after admission. The Medical Ethics Committee of the AMC approved both studies. In this substudy, only patients with a known malignancy at the time of admission or a alignancy first diagnosed during admission were included. m
Data collection
The methods of the two studies were similar: within 48 hours of admission, a multidisciplinary evaluation was performed by a geriatric consultation team. This team consisted of two medical specialists, a geriatric resident, a clinical nurse specialist and two research nurses trained in geriatric medicine. Data on social and demographic status were collected. Patients were assessed for the following geriatric conditions: polypharmacy, malnutrition, incontinence, falls, the ability to perform (instrumental) activities of daily living (ADL and IADL), and cognitive impairment two weeks prior to admission, neurosensory deficits, mobility disorders, and delirium. Furthermore, patients in the DEFENCE-II study were assessed for the presence of pain, constipation, pressure ulcers, health status, depressive symptoms and caregiver burden. Appendix 1 lists the tools used in the assessment. All variables were dichotomized, using the cut-offs described in this appendix.
Medical history and oncologic treatment prior to, during and after hospital stay were collected from patients' medical records by a geriatrician. Based on the treatment during and after hospitalization, patients were subdivided in two groups: those still receiving active anti-cancer treatment (both curative and palliative, i.e. chemotherapy, radiotherapy and/or surgical therapy) and those receiving supportive or symptomatic care only. The reason for admission was collected from the discharge report and classified as directly tumour-related, treatment-related or due to another cause. These reports were also used to derive the Charlson comorbidity index, 32 excluding the current malignancy. The Charlson score is a continuous variable, with scores range from 0-1 with higher scores indicating more or more severe comorbidities. 3
Follow up and definition of outcomes
Follow-up consisted of a telephone interview by a research nurse at three and twelve months after discharge, in which the modified Katz ADL index was re-administered. Follow-up was completed by the same person (patient or primary caregiver) interviewed at baseline. Functional decline was defined as a loss of one or more ADL activities at three or twelve months as compared to premorbid function, two weeks prior to hospital admission. Data n mortality were collected from the Municipal Data Registry. o
Statistical Analysis
Patients receiving active treatment and those receiving supportive care only after admission were compared with one another, for differences in age, comorbidity, the presence of geriatric syndromes, as well as for mortality and functional decline. The chisquare test and risk analysis were used for nominal and ordinal variables, as well as for continuous variables with a non-normal distribution; for continuous variables with a normal distribution, the Student t-test was used.
To determine which baseline factors and geriatric conditions were associated with mortality in the twelve months following admission, a Cox regression analysis was performed. For each variable, the Cox proportional hazards assumption was tested using the log minus log plot. Next, a univariate Cox-regression analysis was performed to determine which variables were associated with mortality in the twelve months following admission. Factors with a p-value <0.20 in the univariate analysis and with less than 20% missing data, were included in the multivariate analysis. A backward selection procedure was applied, accepting a p-value of p<0.05. Kaplan Meier survival plots, with a log-rank analysis, were used to determine survival in the twelve months after admission. The SPSS (Statistical Package for the Social Sciences) version 16.0 was used for the analyses.
Results
Characteristics of acutely hospitalized older cancer patients
In total, 1286 patients were included in the two studies, of which 208 had a known, active malignancy (16%), and 84 were diagnosed with cancer during admission (7%). Baseline characteristics are listed in Table 1 . Median age was 74.9 years (range 65.0 -96.2 years) and 95% of patients lived independently. A total of 27 different types of malignancies were present (Appendix 2). A total of 126 patients (43%) had metastatic disease. 
Prevalence of geriatric conditions
A high prevalence of geriatric conditions was seen, particularly of IADL impairment (77%), pain (65%), depressive symptoms (65%), polypharmacy (48%), mobility problems (48%), malnutrition (46%), high caregiver burden (44%) and ADL impairment (38%) ( Table 2) . On average, patients had four geriatric conditions while only 9% had no geriatric conditions The prevalence increased with age, as patients aged 65-69 years had 2.9 conditions on average, patients aged 70-79 years had 4.1 conditions, and those aged 80 and older had 5.5 conditions (p<0.001). Mean Charlson comorbidity index, excluding the current malignancy, was 1.1 (standard deviation 1.1). 
Differences between patients receiving active vs. supportive care
We were unable to classify five patients as either receiving active or supportive care due to missing follow-up data. Of the remaining patients, 137 (48%) received only symptomatic or supportive care; for newly diagnosed patients, this percentage was much lower than for patients with a known cancer diagnosis (16% vs. 60%, p<0.001). Patients receiving supportive care only had a higher level of education, and higher Charlson comorbidity index. Interestingly, they did not differ in age (Table 1) or the presence of geriatric conditions (Table 2 ) from those receiving active care. 
Outcomes
Mortality rates were 11% in hospital, 38 % at three months and 64% at twelve months. Of patients still alive at follow-up, 8% experienced functional decline at three months, as determined by a decline of one or more in ADL abilities in comparison to premorbid function, two weeks prior to hospitalization. At twelve months, 33% of patients showed functional decline Table 3 shows the Cox-regression analysis for factors associated with twelve-monthmortality. Only metastatic disease (HR 1.67, 95% CI 1.23-2.29) and a tumour-related reason for admission (HR 1.57, 95%CI 1.12-2.21) were independent predictors of outcome, while age, sex, and comorbidity were not. Active oncological treatment did not give any significant survival benefit in comparison to supportive care only ( Figure 1) ; at three months, mortality rate was 36.7% for patients receiving active treatment vs. 38.7% in those receiving supportive care only. At twelve months, mortality was 62.7% vs. 65.7% respectively.
Because several geriatric conditions were not included in the DEFENCE-I study, we also performed a separate multivariate analysis using only the data of the DEFENCE-II study. This analysis yielded similar results for factors associated with mortality within twelve onths. m
Discussion
To our knowledge, this is the first prospective, in-patient study addressing the prevalence of geriatric conditions and their association with outcome in acutely hospitalized older cancer patients. Recent observations demonstrated that several geriatric conditions were predictive of outcome in older cancer patients in out-patient settings. 6, 11, 12 In the present study, we demonstrated that in our population of 292 acutely hospitalized older cancer patients, most of whom were living independently prior to admission, geriatric conditions were highly prevalent, but none of the elements of the CGA were associated with mortality.
The high prevalence of geriatric conditions we found, was also seen in a hospital-based, retrospective study, which reported comparable rates of functional limitations, impaired mobility, malnutrition and depression. 17 Interestingly, we found no differences in the presence of geriatric conditions between patients receiving active care, and those receiving supportive care only. Also, receiving active oncologic treatment did not influence mortality rates compared to receiving supportive care only. Of course, oncologic treatment is not only aimed at improved survival but also improved quality of life, a factor not incorporated in this study. In our study, 8% of cancer patients experienced an increased ADL-dependency three months after discharge, and over 33% at twelve months. We found no prior studies that addressed functional decline after acute hospitalization in older cancer patients. A study by Covinsky et al. looked at loss of ADL abilities after hospitalization for any acute medical illness in patients aged 70 and over -without specifically investigating cancer patients. 33 In their cohort, as many as 35-50% of older patients experienced increased disability (defined by a loss of one or more ADL-abilities) three months after acute hospitalization. The difference with our findings could be explained by differences in the study population, as the cancer patients included in our analysis were younger, had less comorbidity, less functional impairment and less cognitive impairment at baseline, all of which are factors potentially associated with functional decline. 34 For acutely hospitalized patients, the value of CGA in predicting mortality seems to be low. We found that none of the geriatric conditions were associated with mortality within twelve months of admission. This outcome differs from several other studies in an outpatient setting addressing the association between geriatric conditions and outcome; age, 12 comorbidity, 12 ADL-and IADL-dependency, 11 and depression, 6 were found to predict 134 mortality in older cancer patients in this setting. However, in these patients, geriatric assessment was often administered prior to the onset of oncologic treatment with curative intent. Therefore, patients were in a different phase of disease than the patients in our study. Most likely, for these acutely admitted older cancer patients, the presence or absence of geriatric conditions had little further impact on outcome, probably because of the severity of the cancer and cancer-related symptoms: 66% was admitted for a directly tumour-related reason, over 43% had metastases, 48% received only supportive care and 64% died within twelve months. This could also explain why mortality was not associated with age or comorbidity.
In patients with a poor prognosis, the goal of care generally shifts from cure to palliation. Potentially, identifying geriatric conditions at the time of hospital admission can provide the treating physician with leads for improving quality of life. For example, in a study comparing geriatric care for older patients with cancer to care as usual, geriatric care improved quality of life, although there was no difference in survival. 14 Because of the high prevalence of geriatric conditions in our study, and the fact that geriatric conditions are easily missed if not specifically looked for, [7] [8] [9] 15 assessing patients for modifiable geriatric conditions seems appropriate when aiming to optimize quality of hospital and palliative care for older cancer patients. There are several limitations to this study. First of all, the study population forms a heterogeneous group, with different types of malignancies in different stages of disease. Furthermore, because two of the three hospitals are tertiary referral centres, there is a potential referral bias, resulting in a less frail population as well as an overrepresentation of upper gastro-intestinal tract tumours -for which the Academic Medical Centre is a national centre -compared to regional hospitals. This potentially influences the generalizability of our findings. For example, the low cancer-specific survival rates of the upper GI tract malignancies could have decreased the value of the CGA for predicting mortality. A second limitation is that this is a post-hoc analysis of two studies, whose designs were highly but not entirely similar. Some geriatric conditions addressed in the DEFENCE-II study were not included in the DEFENCE-I study, therefore resulting in a missing data for these items. The effect on the outcomes of this study seems low, however, as analyses with only the data from the DEFENCE-II study did not lead to different results. Due to the high mortality rates at three and twelve months, we were nable to test which factors at baseline were associated with functional decline. u
In conclusion, our study demonstrates geriatric conditions are highly prevalent in older cancer patients admitted for an acute illness. Based on prior literature, we assume that using a CGA for older cancer patients acutely admitted to hospital may have added value for improving quality of life. None of the elements of the CGA were of value in predicting mortality, as outcome in this population was only associated with cancer-related factors.
To elucidate the exact role of CGA, future research comparing quality of life and outcome in patients receiving either care as usual or specific interventions aimed at modifying the geriatric conditions identified by a CGA, is needed. 31 was <16 *** In the DEFENCE-I study, the Katz was filled out by the patient if MMSE 31 was >23. If it was lower, the primary caregiver filled out the Katz. In the DEFENCE-II study, the Katz was filled out by the patient if the MMSE was >20; filled out by the patient and double-checked with the caregiver if MMSE was 16 to 20; and filled out by the caregiver only if MMSE was <16.
